Carolina Girotto Pressete

Carolina Girotto Pressete

Auto-generated profile, based on publicly available information

Carolina Girotto Pressete

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
ANAmanda Alvim Negreti
Amanda Alvim Negreti
GFGuilherme Álvaro Ferreira-Silva
Guilherme Álvaro Ferreira-Silva
CPCarolina Girotto Pressete
Carolina Girotto Pressete
RFRafael Fonseca
Rafael Fonseca
Caio Cesar CandidoCaio Cesar Candido
Caio Cesar Candido
MIMarisa Ionta
Marisa Ionta
Melanoma is a highly aggressive skin cancer with a limited targeted therapy arsenal. Ruthenium-based complexes have shown interesting pro-apoptotic effects on malignant tumor cell lines. In this study three ruthenium(II) complexes containing cinnamic acid derivatives as ligands were synthesized and characterized and their cytotoxic profile was evaluated on four melanoma cell lines (HT-144, SK-MEL-147, CHL-1, and WM1366). All complexes significantly reduced cell viability in a concentration-dependent manner. However, complex (2) bearing trans-4-(trifluoromethyl)cinnamic acid as the ligand was the most promising compound. We demonstrated that complex (2) inhibits cell cycle progression at the G1 phase and induces apoptosis in the CHL-1 cell line. Our data showed that cell cycle arrest at G1/S transition was, at least in part, due to reduction of ERK activation, CDKN1A (p21) upregulation and CCNE2 (cyclin E2) downregulation. Moreover, pro-apoptotic activity of complex (2) was ascribed to its ability to modulate BAX and Bcl-2 expression profiles leading to an increase in the BAX/Bcl-2 ratio. We also demonstrated that complex (2) affects the actin cytoskeleton organization pattern and inhibits the migration of CHL-1. Taken together, the data indicate the promising antitumor potential of complex (2) against melanoma cells and support further in vivo studies.

1 July 2025 in ACS Omega
Verified
Journal Article
Open access
GFGuilherme Ferreira-Silva
Guilherme Ferreira-Silva
Caio Cesar CandidoCaio Cesar Candido
Caio Cesar Candido
GGGraciana Yokota Garavelli
Graciana Yokota Garavelli
CPCarolina Girotto Pressete
Carolina Girotto Pressete
ECEster Siqueira Caixeta
Ester Siqueira Caixeta
AAAlexandre Ferro Aissa
Alexandre Ferro Aissa
Lung cancer is the leading cause of cancer-related deaths globally, with nonsmall cell lung cancer (NSCLC) being the most prevalent type. Cisplatin and its derivatives are commonly used in classical chemotherapy, but their therapeutic efficacy is limited, and they came with significant side effects. The targeted therapies and immunotherapy have improved survival rates for certain groups of patients. However, overall survival for NSCLC remains very low, which contributes to the high mortality rate. Thus, the search for effective and affordable drugs is ongoing. In this context, ruthenium-based complexes have been extensively studied as promising anticancer agents. In our previous studies, three ruthenium­(II) complexes containing cinnamic acid derivatives with ligands were synthesized and characterized. We demonstrated that the complex [Ru­(trans-4-(trifluoromethyl)­cinnam)­(dppb)­(bipy)]­PF6 effectively inhibited the proliferation of melanoma cells with either an activating N-Ras mutation or a TP53 inactivation mutation. Therefore, in this study, we aimed to evaluate the antitumor potential of complex [Ru­(3,4-cinnam)­(dppb)­(bipy)]­PF6, named CINNAM, against nonsmall cell lung cancer cells A549 (TP53 wild type; K-Ras mutated) and H1299 (TP53 mutated; N-Ras mutated). CINNAM selectively targeted cancer cells over normal cells, with A549 cells showing higher sensitivity to the CINNAM compared to H1299 cells. CINNAM effectively reduced the proliferation of A549 cells by inducing cell cycle arrest at the G0/G1 phase. CINNAM modulated the expression profiles of key cell cycle regulators, CDKN1A, CCND1, and CCNE2. Further, we demonstrated that the cytotoxic activity of CINNAM is linked to its pro-oxidant and pro-apoptotic properties. The interactions of the complex with ct-DNA (calf thymus DNA) were analyzed, and based on the Kb value, the complex present intermediate affinity for DNA. In conclusion, CINNAM exhibits potent antiproliferative and pro-apoptotic effects on NSCLC cells, surpassing those observed with cisplatin.

13 July 2023 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
DRDayana Alves Rodrigues
Dayana Alves Rodrigues
BSBianca Lana de Sousa
Bianca Lana de Sousa
CPCarolina Girotto Pressete
Carolina Girotto Pressete
JSJúnio Gonçalves Silva
Júnio Gonçalves Silva
BZBruno Zavan
Bruno Zavan
MSMarcelo Dos Santos
Marcelo Dos Santos
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide. The mortality rate has not reduced despite introducing new therapeutic approaches such as immunotherapy and target-directed therapies. Drug resistance represents a challenge for HCC treatment, resulting in the search for new drug candidates. In the present study, a series of triazole derivatives of guttiferone-A were synthesized and tested against non-small-cell lung cancer (A549), hepatocellular carcinoma (HepG2), and estrogen-positive breast carcinoma (MCF-7) cell lines. Compounds 6, 10, and 12 displayed significant cytotoxic activity on A549 and HepG2 cells, and compound 10 was highly selective toward HepG2 cells. Compound 10 inhibited MAPK/ERK signaling and modulated the expression of critical regulators of the cell cycle progression in HepG2 cells. There was a significant reduction of the cyclins D/E, while p21 was upregulated, indicating that the antiproliferative activity of compound 10 on HepG2 cells, at least in part, is associated with its ability to modulate the expression profile of regulators of G1/S transition. Our findings showed that triazole derivatives of guttiferone-A may be useful as anticancer prototypes and support further in vivo investigation to evaluate the efficiency of compound 10 in suppressing HCC growth and progression.

30 August 2021 in Revista Brasileira de Ciências da Saúde
Verified
Journal Article
Closed access
PDF file
CPCarolina Girotto Pressete
Carolina Girotto Pressete
FVFernanda de Carvalho Vidigal
Fernanda de Carvalho Vidigal
DLDaniela Braga Lima
Daniela Braga Lima
Objetivo: Determinar o estado nutricional de universitários da área de saúde de uma Instituição Federal de Ensino Superior. Metodologia: Trata-se de estudo epidemiológico transversal com universitários matriculados nos cursos presenciais da área de saúde de uma Instituição Federal de Ensino Superior do Sul de Minas Gerais. Coletaram-se dados demográficos e socioeconômicos, histórico familiar de doenças crônicas não transmissíveis, estado de saúde e autoavaliação nutricional. Foram aferidas as medidas antropométricas e coletadas informações sobre os hábitos alimentares e a prática de atividade física. A análise estatística foi realizada no software Stata SE. Resultados: Dos 180 universitários, 82,2% eram do sexo feminino, com média de idade de 21 anos. Observou-se sedentarismo em 51,1% dos universitários. A maioria dos estudantes não apresentava nenhuma doença autorreferida (70,5%). Em relação ao estado nutricional, 29,5% dos participantes apresentavam excesso de peso, atingindo 45,5% dos homens e 25,9% das mulheres. Evidenciou-se uma correlação estatisticamente significante e positiva entres as variáveis: índice de massa corporal e circunferência da cintura e índice de massa corporal e percentual de gordura corporal. A alimentação foi considerada inadequada para a maioria dos estudantes. Conclusão: Constatou-se excesso de peso, em quase um terço dos universitários e alimentação inadequada. Desta forma, verificou-se a necessidade de adoção de estratégias educativas que enfatizem a importância da alimentação saudável para a prevenção de agravos à saúde, principalmente, pelo fato desses universitários serem futuros profissionais da área da saúde.

6 February 2026 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
PDF file
KRKátia Regina Ribeiro
Kátia Regina Ribeiro
RSRúbia Bellard e Silva
Rúbia Bellard e Silva
JSJéssica Thaianny Ferreira Souza
Jéssica Thaianny Ferreira Souza
LPLaura Jéssica Pereira
Laura Jéssica Pereira
YSYasmim Raffaela Soares Santos
Yasmim Raffaela Soares Santos
RCRenê Couto
Renê Couto
The Celtis iguanaea (Jacq.) Sarg., Cannabaceae, standardized spray-dried extract, underwent acute safety evaluation using a range of alternative toxicological models in alignment with Organization for Economic Co-operation and Development Test Guidelines. Acute aquatic toxicity was assessed using the Artemia salina lethality test (LC 50 418.4 μg/ml) and the zebrafish ( Danio rerio ) embryo toxicity test (OECD TG 236; LC 50 1116.0 μg/ml). According to the Globally Harmonized System aquatic toxicity categories, C. iguanaea spray-dried extract is classified as non-hazardous (LC 50 > 100 μg/ml). In vitro assays included cytotoxicity (methyl thiazolyl tetrazolium assay –in WI-38 and HaCaT cells; resazurin in Caco-2 and HT-29 cells), cell adhesion genotoxicity (comet assay; OECD TG 489), and mutagenicity (cytokinesis-block micronucleus assay; OECD TG 487). Celtis iguanaea spray-dried extract showed no cytotoxic, genotoxic, or mutagenic effects up to 250 μg/ml and enhanced HaCaT cell viability and adhesion at higher concentrations (100 μg/ml), suggesting potential support for wound healing. No antimicrobial activity was observed against Candida spp., ESKAPE pathogens, or bacteria associated with urinary tract infections (MIC > 1024.0 μg/ml). This weight-of-evidence assessment supports the safe use of C. iguanaea spray-dried extract in topical or oral formulations and provides data suitable for regulatory hazard characterization and acute risk assessment. Graphical Abstract